Optimal Dosage and Method of Administration of Adenosine for Measuring the Coronary Flow Reserve and the Fractional Flow Reserve in Koreans.
10.4070/kcj.2006.36.4.300
- Author:
Jung Won SUH
1
;
Bon Kwon KOO
;
Sang Ho JO
;
Hyun Jae KANG
;
Young Seok CHO
;
Tae Jin YOUN
;
Woo Young CHUNG
;
In Ho CHAE
;
Dong Ju CHOI
;
Hyo Soo KIM
;
Byung Hee OH
;
Young Bae PARK
Author Information
1. Department of Internal Medicine, Seoul National University College of Medicine, Seoul, Korea. bkkoo@snu.ac.kr
- Publication Type:Original Article
- Keywords:
Adenosine;
Coronary flow reserve
- MeSH:
Adenosine*;
Coronary Vessels;
Humans;
Hyperemia;
Infusions, Intravenous;
Vasodilation
- From:Korean Circulation Journal
2006;36(4):300-307
- CountryRepublic of Korea
- Language:Korean
-
Abstract:
BACKGROUND AND OBJECTIVES: The achievement of maximal vasodilatation is mandatory for obtaining valid measurements of the coronary flow reserve (CFR) and the fractional flow reserve (FFR). Recent studies have indicated that an incremental dose or a high dose of adenosine is necessary to achieve maximal hyperemia. We performed this study to examine the response of the physiologic parameters to different doses and to different methods of administration of adenosine in Koreans. SUBJECTS AND METHODS: CFR: The CFR was measured in 25 consecutive patients with angiographically normal coronary arteries by using a Doppler wire. Three different doses (9, 18 and 36 microgram in the left coronary artery (LCA), and 6, 12 and 24 microgram in the right coronary artery (RCA)) of adenosine were used. FFR: In a phase I study, 102 consecutive patients with 188 intermediate lesions (160 LCA and 28 RCA lesions) underwent FFR measurements with using a pressure wire. Three different bolus doses (20, 40 and 80 microgram) were administered in an incremental fashion. In a phase II study, the hyperemic efficacy of 3 different doses of intracoronary (IC) infusion (180, 240 and 300 microgram/min) and of 3 methods of administration (IC infusion, intravenous infusion and IC bolus) were compared. RESULTS: CFR: The higher 2nd dose of adenosine had a tendency to achieve a higher CFR than the lower 1st dose. But when we increased the adenosine to more than 20 microgram (LCA 36 and RCA 24 microgram), there was a tendency towards obtaining a lower CFR than that obtained after the 2nd dose of adenosine (LCA: 2.78+/-0.71 vs. 2.66+/-0.60, p=0.055, RCA: 3.19+/-0.88 vs. 3.04+/-0.80, p=0.86). FFR: Phase I: The dose of adenosine that achieved maximal hyperemia was 51+/-16 microgram in the LCA and 35+/-20 microgram in the RCA. In 73 (46%) of the LCA lesions and 12 (42%) of the RCA lesions, a further reduction of the FFR occurred when a higher dose of adenosine was used (LCA>40 ug, RCA>20 microgram). Phase II: The FFR obtained after an IC bolus injection (0.83+/-0.06) was significantly higher than obtained with an IV infusion (0.79+/-0.07) and an IC (0.78+/-0.09) infusion (p<0.01). However, no difference in the FFR was observed for the IC and IV infusions. CONCLUSION: This study suggests that more than 20 microgram adenosine does not have an additive effect on measuring the CFR. Adenosine 40 microgram for the LAD and 20 microgram for the RCA seems to be optimal as a intracoronary bolus injection for measuring the FFR in most cases. However, for the patients with borderline FFR, a higher bolus adenosine dose or an adenosine continuous infusion may be necessary.
